Literature DB >> 6156953

Inhibition of polymorphonuclear leukocyte chemiluminescence for detection of immune complexes in human sera.

N J Doll, M R Wilson, J E Salvaggio.   

Abstract

An assay for the detection and quantitation of immune complexes is described. Experimental immune complexes or aggregated human gamma globulin (AHG) were incubated with polymorphonuclear leukocytes (PMN). After challenge of the PMN with opsonized zymosan, chemiluminescence was recorded in a scintillation spectrometer. A quantitative inhibition of chemiluminescence could be demonstrated by the interaction of PMN with immune complexes or AHG. Experimental immune complexes of bovine serum albumin-anti-bovine serum albumin were formed and tested by this assay, and immune complexes formed near antigen excess were best described by this technique. The technique was used to demonstrate immune complexes in the sera from patients with systemic lupus erythematosus, rheumatoid arthritis, and vasculitis. Immune complexes were quantitated by reference to a standard curve using AHG. By this technique, normal human sera had < 10 micrograms of AHG per milliliter of serum. Immune complexes at levels above this were detected in 9/15 patients with systemic lupus erythematosus, 18/30 patients with rheumatoid arthritis, and 2/5 patients with vasculitis. Therefore, this assay is a sensitive, simple method for measurement of circulating immune complexes in the sera of patients with certain connective tissue diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156953      PMCID: PMC371673          DOI: 10.1172/JCI109876

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Interaction of cells with immune complexes: adherence, release of constituents, and tissue injury.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

2.  The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

3.  Leucocyte-specific anti-nuclear factors in patients with felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases.

Authors:  V Faber; P Elling
Journal:  Acta Med Scand       Date:  1966-03

4.  Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles.

Authors:  G Weissmann; R B Zurier; P J Spieler; I M Goldstein
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis.

Authors:  I M Goldstein; F Feit; G Weissmann
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

6.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.

Authors:  V Agnello; R J Winchester; H G Kunkel
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

7.  The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses.

Authors:  P M Henson; H B Johnson; H L Spiegelberg
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

8.  C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types.

Authors:  V Agnello; D Koffler; J W Eisenberg; R J Winchester; H G Kundel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.

Authors:  R J Winchester; H G Kunkel; V Agnello
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

View more
  5 in total

1.  Joint fluid leukocyte activation by preformed immune complexes.

Authors:  P Thomsen; L M Bjursten; L E Ericson
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

2.  Neutrophil activation by immune complexes and the role of rheumatoid factor.

Authors:  R Gale; J V Bertouch; T P Gordon; J Bradley; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

3.  Effect of glomerular basement membrane on the initiation of chemiluminescence and lysosomal enzyme release in human polymorphonuclear leucocytes: an in vitro model of glomerular disease.

Authors:  M Davies; G A Coles; M J Harber
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

4.  Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid.

Authors:  R Gale; J V Bertouch; J Bradley; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

5.  Differential generation of chemiluminescence--detectable oxygen radicals by normal polymorphonuclear leukocytes challenged with sera from systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  C D'Onofrio; F E Maly; H Fischer; D Maas
Journal:  Klin Wochenschr       Date:  1984-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.